Breaking Down Barriers in Healthcare: Urgency for the Clinical Laboratory to Migrate from the Background to the Forefront of Patient Care

The movement towards value-based healthcare has provided a platform for a better future for all involved in the health ecosystem. However, amongst the multitude of value initiatives, the clinical laboratory has largely been left to play a secondary role. Despite its core value principles of data, timely and efficient diagnosis, and patient centricity, the lab has been relegated to near-commodity status. This is also indicative of a broader problem: a fragmented value chain that underexploits sources in decision-making, at a time when the health world’s stated focus is on outcomes.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Evolution of Hematopoietic Stem Cell Gene Therapy

workcast

In the nearly two decades since the first successful use of gene therapy, transplantation of gene modified autologous hematopoietic stem cells (HSCs) is emerging as a viable treatment for a number of genetic blood cell and metabolic diseases and for some may even become standard of care.
Watch Now

A Hybrid Approach to Continuous Biomanufacturing of Biosimilars

There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end operations
Watch Now

Process and Facility Design Considerations for CGT Manufacturing

Viral Vector therapies are gaining increasing traction with more and more companies looking to take the leap from other Biologics. In the early stages of clinical development, it’s expedient to outsource to de-risk the venture.
Watch Now

Using non-hypothesized based approaches for biomarker development

Current protein biomarkers are only moderately predictive in identifying individuals with mild traumatic brain injury or concussion. Therefore, more accurate diagnostic markers are needed for sport-related concussion.
Watch Now

Spotlight

resources